DAMPs and influenza virus infection in ageing

Ageing Research Reviews

Volumn 24, Issue , 2015, Pages 83-97

  Samy, Ramar Perumal ^a   Lim, Lina H K ^a  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

Ageing; Alarmins; DAMPs; Influenza A virus; Nuclear factor kappa B; Pro inflammatory cytokines; Toll like receptors

Indexed keywords

ANNEXIN; DAMAGE ASSOCIATED MOLECULAR PATTERN; HIGH MOBILITY GROUP B1 PROTEIN; INFLAMMASOME; INFLUENZA VACCINE; PROTEIN; PROTEIN S 100; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

AGING; BACTERIAL INFECTION; CYTOKINE STORM; DISEASE SEVERITY; HUMAN; IMMUNE SYSTEM; INFLAMMATION; INFLUENZA; INFLUENZA VACCINATION; INNATE IMMUNITY; MORBIDITY; MORTALITY; NONHUMAN; REVIEW; T LYMPHOCYTE; ANIMAL; IMMUNOLOGY; INFLUENZA A VIRUS; METABOLISM; ORTHOMYXOVIRUS INFECTION; PATHOLOGY;

AGING; ANIMALS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE INFECTIONS;

EID: 84947029666     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2015.07.005     Document Type: Review

References (309)

1. Agrawal A., Agrawal S., Tay J., Gupta S. Biology of dendritic cells in aging. J. Clin. Immunol. 2008, 28:14-20.
2. Ahmed M., Lanzer K.G., Yager E.J., Adams P.S., Johnson L.L., Blackman M.A. Clonal expansions and loss of receptor diversity in the naive CD8 T cell repertoire of aged mice. J. Immunol. 2009, 182:784-792.
3. Alexandrova E.A., Beltchev B.G. Differences between HMG1 proteins isolated from normal and tumour cells. Biochim. Biophys. Acta 1987, 915:399-405.
4. Allen I.C., Jania C.M., Wilson J.E., Tekeppe E.M., Hua X., Brickey W.J., Kwan M., Koller B.H., Tilley S.L., Ting J.P. Analysis of NLRP3 in the development of allergic airway disease in mice. J. Immunol. 2012, 188:2884-2893.
5. Allen I.C., Scull M.A., Moore C.B., Holl E.K., McElvania-Tekippe E., Taxman D.J., Guthrie E.H., Pickles R.J., Ting J.P. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 2009, 30:556-565.
6. Alves Galvao M.G., Rocha Crispino Santos M.A., Alves da Cunha A.J. Amantadine and rimantadine for influenza A in children and the elderly. Cochrane Database Syst. Rev. 2012, 1:CD002745.
7. Andersson U., Wang H., Palmblad K., Aveberger A.C., Bloom O., Erlandsson Harris H., et al. High mobility group 1 protein (HMG-1) stimulates proin-flammatory cytokine synthesis in human monocytes. J. Exp. Med. 2000, 192:565-570.
8. Arias E., Anderson R.N., Kung H.C., Murphy S.L., Kochanek K.D. Deaths: final data for 2001. Natl. Vital Stat Rep. 2003, 52:1-116.
9. Aspinall R., Del Giudice G., Effros R.B., Grubeck-Loebenstein B., Sambhara S. Challenges for vaccination in the elderly. Immun. Ageing 2007, 4(1):9.
10. Atallah M., Krispin A., Trahtemberg U., Ben-Hamron S., Grau A., Verbovetski I., Mevorach D. Constitutive neutrophil apoptosis: regulation by cell concentration via S100 A8/9 and the MEK-ERK pathway. PLoS One 2012, 7:e29333.
11. Barja G. Free radicals and aging. Trends Neurosci. 2004, 27:595-600.
12. Barnard D.L. Animal models for the study of influenza pathogenesis and therapy. Antiviral Res. 2009, 82:A110-A122.
13. Baroja-Mazo A., Martin-Sanchez F., Martinez C.M., Amores-Iniesta J., Compan V., Yague J., Ruiz-Ortiz E., Anton J., Bujan S., Couillin I., Brough D., Arostegui J.I., Pelegrin P. The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response. Nat. Immunol. 2014, 15:738-748.
14. Barrett J.P., Costello D.A., O'Sullivan J., Cowley T.R., Lynch M.A. Bone marrow-derived macrophages from aged rats are more responsive to inflammatory stimuli. J. Neuroinflammation 2015, 12:67.
15. Baskin C.R., Bielefeldt-Ohmann H., Tumpey T.M., Sabourin P.J., Long J.P., Garcia-Sastre A., Tolnay A.E., Albrecht R., Pyles J.A., Olson P.H., Aicher L.D., Rossenzweig E.R., Murali-Krishna K., Clark E.A., Kotur M.S., Fornek J.L., Proll S., Palmero R.E., Sabourin C.L., Katze M.G. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:3455-3460.
16. Beli E., Clinthorne J.F., Duriancik D.M., Hwang I., Kim S., Gardner E.M. Natural killer cell function is altered during the primary response of aged mice to influenza infection. Mech. Ageing Dev. 2011, 132:503-510.
17. Bermejo-Martin J.F., Ortiz De Lejarazu R., Pumarola T., Rello J., Almansa R., Ramírez P., Martin-Loeches I., Varillas D., Gallegos M.C., Serón C., Micheloud D., Gomez J.M., Tenorio-Abreu A., Ramos M.J., Molina M.L., Huidobro S., Sanchez E., Gordón M., Fernández V., Del Castillo A., Marcos M.A., Villanueva B., López C.J., Rodríguez-Domínguez M., Galan J.C., Cantón R., Lietor A., Rojo S., Eiros J.M., Hinojosa C., Gonzalez I., Torner N., Banner D., Leon A., Cuesta P., Rowe T., Kelvin D.J. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit. Care 2009, 13:R201.
18. Bianchi M.E. DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 2007, 81:1-5.
19. Biragyn A., Coscia M., Nagashima K., Sanford M., Young H.A., Olkhanud P. Murine β-defensin 2 promotes TLR-4/MyD88-mediated and NF-κ B-dependent atypical death of APCs via activation of TNFR2. J. Leukoc. Biol. 2008, 83:998-1008.
20. Blasco M.A. Telomere length, stem cells and aging. Nat. Chem. Biol. 2007, 3:640-649.
21. Bode G., Lüken A., Kerkhoff C., Roth J., Ludwig S., Nacken W. Interaction between S100A8/A9 and annexin A6 is involved in the calcium-induced cell surface exposition of S100A8/A9. J. Biol. Chem. 2008, 283:31776-31784.
22. Boehmer E.D., Meehan M.J., Cutro B.T., Kovacs E.J. Aging negatively skews macrophage TLR2- and TLR4-mediated pro-inflammatory responses without affecting the IL-2-stimulated pathway. Mech. Ageing Dev. 2005, 126:1305-1313.
23. Boon A.C., Fringuelli E., Graus Y.M., Fouchier R.A., Sintnicolaas K., Iorio A.M., Rimmelzwaan G.F., Osterhaus A.D. Influenza A virus specific T cell immunity in humans during aging. Virology 2002, 299:100-108.
24. Bour-Jordan H., Esensten J.H., Martinez-Llordella M., Penaranda C., Stumpf M., Bluestone J.A. Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/B7 family. Immunol. Rev. 2011, 241:180-205.
25. Broggi A., Granucci F. Microbe- and danger-induced inflammation. Mol. Immunol. 2014, S0161-S5890.
26. Broz P., Monack D.M. Molecular mechanisms of inflammasome activation during microbial infections. Immunol. Rev. 2011, 243:174-190.
27. Brundage J.F. Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness. Lancet Infect. Dis. 2006, 6:303-312.
28. Bustin M., Lehn D.A., Landsman D. Structural features of the HMG chromosomal proteins and their genes. Biochim. Biophys. Acta 1990, 1049:231-243.
29. Castle S.C. Clinical relevance of age-related immune dysfunction. Clin. Infect. Dis. 2000, 31:578-585.
30. Cavanagh M.M., Weyand C.M., Goronzy J.J. Chronic in 452 flammation and aging: DNA damage tips the balance. Curr. Opin. Immunol. 2012, 24:488-493.
31. Cerbulo-Vazquez A., Figueroa-Damian R., Arriaga-Pizano L.A., Hernandez-Andrade E., Mancilla-Herrera I., Flores-Mejia L.A., Arteaga-Troncoso G., Lopez-Macias C., Isibasi A., Mancilla-Ramirez J. Pregnant women infected with pandemic H1N1pdm200 influenza virus displayed overproduction of peripheral blood CD69+ lymphocytes and increased levels of serum cytokines. PLoS One 2014, 25(9):e107900.
32. Chan J.K., Roth J., Oppenheim J.J., Tracev K.J., Vogl T., Feldmann M., Horwood N., Nanchahal J. Alarmins: awaiting a clinical response. J. Clin. Invest. 2012, 122:2711-2719.
33. Chen G., Ward M.F., Sama A.E., Wang H. Extracellular HMGB1 as a proinflammatory cytokine. J. Interferon Cytokine Res. 2004, 24:329-333.
34. Chung H.Y., Cesari M., Anton S., Marzetti E., Giovannini S., Seo A.Y., Leeuwenburgh C. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res. Rev. 2009, 8:18-30.
35. Chung H.Y., Kim H.J., Kim K.W., Choi J.S., Yu B.P. Molecular inflammation hypothesis of aging based on the anti-aging mechanism of calorie restriction. Microsc. Res. Tech. 2002, 59:264-272.
36. Chung H.Y., Lee E.K., Choi Y.J., Kim J.M., Kim D.H., Zou Y., Kim C.H., Lee J., Kim H.S., Kim N.D., Jung J.H., Yu B.P. Molecular inflammation as an underlying mechanism of the aging process and age-related diseases. J. Dent. Res. 2011, 90:830-840.
37. Chung J.Y., Han T.H., Kim C.K., Kim S.W. Bocavirus infection in hospitalized children, South Korea. Emerg. Infect. Dis. 2006, 12:1254-1256.
38. Church L.D., Cook G.P., McDermott M.F. Primer: inflammasomes and interleukin 1beta in inflammatory disorders. Nat. Clin. Pract. Rheumatol. 2008, 4:34-42.
39. Cicin-Sain L., Messaoudi I., Park B., Currier N., Planer S., Fischer M., Tackitt S., Nikolich-Zugich D., Legasse A., Axthelm M.K., Picker L.J., Mori M., Nikolich-Zugich J. Dramatic increase in naive T cell turnover is linked to loss of naive T cells from old primates. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:19960-19965.
40. Cicin-Sain L., Smyk-Pearson S., Currier N., Byrd L., Koudelka C., Robinson T., Swarbrick G., Tackitt S., Legasse A., Fisher M., Nikolich-Zugich D., Park B., Hobbs T., Doane C.J., Mori M., Axthelm M.K., Lewinsohn D.A., Nikolich-Zugich J. Loss of naive T cells and repertoire constriction predict poor response to vaccination in old primates. J. Immunol. 2010, 184:6739-6745.
41. Cilloniz C., Shinya K., Peng X., Korth M.J., Proll S.C., Aicher L.D., Carter V.S., Chang J.H., Kobasa D., Feldman F., Strong J.E., Feldmann H., Kawaoka Y., Katze M.G. Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathog 2009, 5:e1000604.
42. Coluzzi E., Colamartino M., Cozzi R., Leone S., Meneghini C., Callaghan N.O., Sgura A. Oxidative stress induces persistent telomeric DNA damage responsible for nuclear morphology change in mammalian cells. PLoS One 2014, 9:e110963.
43. Correia-Melo C., Hewitt G., Passos J.F. Telomeres, oxidative stress and inflammatory factors: partners in cellular senescence?. Longevity Healthspan 2014, 3:1-9.
44. d'Adda di Fagagna F., Reaper P.M., Clay-Farrace L., Fiegler H., Carr P., Von Zglinicki T., Saretzki G., Carter N.P., Jackson S.P. A DNA damage checkpoint response in telomere-initiated senescence. Nature 2003, 426:194-198.
45. Dassah M., Deora A.B., He K., Hajjar K.A. The endothelial cell annexin A2 system and vascular fibrinolysis. Gen. Physiol. Biophys. 2009, 28:F20-F28.
46. Davalos A.R., Kawahara M., Malhotra G.K., Schaum N., Huang J., Ved U., Beausejour C.M., Coppe J.P., Rodier F., Campisi J. p53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypes. J. Cell Biol. 2013, 20(1):613-629.
47. Dawood F.S., Iuliano A.D., Reed C., Meltzer M.I., Shay D.K., Cheng P., Bandaranayake D., Breiman R.F., Brooks W.A., Buchy P., Feikin D.R., Fowler K.B., Gordon A., Hien N.T., Horby P., Huang Q.S., Katz M.A., Krishnan A., Lal R., Montgomery J.M., Molbak K., Pebody R., Presanis A.M., Razuri H., Steens A., Tinoco Y.O., Wallinga J., Yu H., Vong S., Bresee J., Widdowson M. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect. Dis. 2012, 12:687-695.
48. de Jong M.D., Simmons C.P., Thanh T.T., Hien V.M., Smith G.J., Chau T.N., Hoang D.M., Chau N.V., Khanh T.H., Dong V.C., Qui P.T., Cam B.V., Ha do Q., Guan Y., Peiris J.S., Chinh N.T., Hien T.T., Farrar J. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 2006, 12:1203-1207.
49. de la Fuente M., Hernanz A., Guayerbas N., Alvarez P., Alvarado C. Changes with age in peritoneal macrophage functions. Implication of leukocytes in the oxidative stress of senescence. Cell. Mol. Biol. (Noisy-le-grand) 2004, 50. Online Pub: OL683-690.
50. de Magalhães J.P., Curado J., Church G.M. Meta-analysis of age-related gene expression profiles identifies common signatures of aging. Bioinformatics 2009, 25:875-881.
51. Decman V., Laidlaw B.J., Doering T.A., Leng J., Ertl H.C., Goldstein D.R., Wherry E.J. Defective CD8 T cell responses in aged mice are due to quantitative and qualitative changes in virus-specific precursors. J. Immunol. 2012, 188:1933-1941.
52. Deng J.C. Viral-bacterial interactions-therapeutic implications. Influenza Other Respir. Viruses 2013, 7(03). 10.1111/irv.12174.
53. Deng Y., Jing Y., Campbell A.E., Gravenstein S. Age-related impaired type 1 T cell responses to influenza: reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly. J. Immunol. 2004, 172:3437-3446.
54. Derek G. TheH1N1 influenza outbreak in its historical context. J. Clin. Virol. 2009, 45:174-178. 2009.
55. Di Virgilio F. Purines, purinergic receptors, and cancer. Cancer Res. 2012, 72:1-7.
56. Diebold S.S., Kaisho T., Hemmi H., Akira S., Reise Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004, 303:1529-1531.
57. Diebold S.S., Kaisho T., Hemmi H., Akira S., Reise Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004, 303:1529-1531.
58. Donowitz G.R., Cox H.L. Bacterial community-acquired pneumonia in older patients. Clin. Geriatr. Med. 2007, 23(3):515-534.
59. Ehrchen J.M., Sunderko C., Foell D., Vogl T., Roth J. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J. Leukoc. Biol. 2009, 86:557-566.
60. 2+ signaling with cholesterol transport. Biochim. Biophys. Acta 2011, 1813:935-947.
61. Feldman C., Anderson R. Bacteraemic pneumococcal pneumonia: current therapeutic options. Drugs 2011, 71:131-153.
62. Finelli L., Fiore A., Dhara R., Brammer L., Shay D.K., Kamimoto L., Fry A., Hageman J., Gorwitz R., Bresee J., Uyeki T. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics 2008, 122:805-811.
63. Fishman J.A. Infection in solid-organ transplant recipients. N. Engl. J. Med. 2007, 357:2601-2614.
64. Flower R.J. Background and discovery of lipocortins. Agents Actions 1986, 17:255-262.
65. Foell D., Wittkowski H., Roth J. Mechanisms of disease: a DAMP view of inflammatory arthritis. Nat. Clin. Pract. Rheumatol. 2007, 3:382-390.
66. Foell D., Wittkowski H., Vogl T., Roth J. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J. Leukoc. Biol. 2007, 81:28-37.
67. Franceschi C. Inflammaging as a major characteristic of old people: can it be prevented or cured. Nutr. Rev. 2007, 65:S173-S176.
68. Franceschi C., Bonafe M., Valensin S., Olivieri F., De Luca M., Ottaviani E., De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 2000, 908:244-254.
69. Franceschi C., Capri M., Monti D., Giunta S., Olivieri F., Sevini F., Panourgia M.P., Invidia L., Celani L., Scurti M., Cevenini E., Castellani G.C., Salvioli S. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing Dev. 2007, 128:92-105.
70. Fritz G., Botelho H.M., Morozova-Roche L.A., Gomes C.M. Natural and amyloid self-assembly of S100 proteins: structural basis of functional diversity. FEBS J. 2010, 277:4578-4590.
71. S6 kinase. Mol. Cell. Biochem. 2004, 267:177-185.
72. Fujino N., Kubo H., Ota C., Suzuki T., Takahashi T., Yamada M., Suzuki S., Kondo T., Nagatomi R., Tando Y., Yamaya M. Increased severity of 2009 pandemic influenza A virus subtype H1N1 infection in alveolar type II cells from patients with pulmonary fibrosis. J. Infect. Dis. 2013, 207:692-693.
73. Gardella S., Andrei C., Ferrera D., Lotti L.V., Torrisi M.R., Bianchi M.E., Rubartelli A. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 2002, 3:995-1001.
74. Geginat J., Lanzavecchia A., Sallusto F. Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines. Blood 2003, 101:4260.
75. Geginat J., Sallusto F., Lanzavecchia A. Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4+ T cells. J. Exp. Med. 2001, 194:1711.
76. George A.J., Ritter M.A. Thymic involution with ageing: obsolescence or good housekeeping. Immunol. Today 1996, 17:267-272.
77. Gharibyan A.L., Raveh D., Morozova-Roche L.A. S100A8/A9 Amyloidosis in the ageing prostate: relating ex vivo and in vitro studies. Methods Mol. Biol. 2012, 849:387-401.
78. Ghavami M., Eshragi S.R., Ande W.J., Chazin T., et al. S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3. Cell. Res. 2010, 20:314-331.
79. Gill A., Long K., Kwon T., et al. Differential recruitment of dendritic cells and monocytes to respiratory mucosal sites in children with influenza virus or respiratory syncytial virus infection. J. Infect. Dis. 2008, 198:1667-1676.
80. Ginaldi L., Loreto M.F., Corsi M.P., Modesti M., De Martinis M. Immunosenescence and infectious diseases. Microbes Infection. 2001, 10:851-857.
81. Glezen W.P., Decker M., Perrotta D.M. Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epi-demics in Houston, 1978-1981. Am. Rev. Respir. Dis. 1987, 136:550-555.
82. 4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol. Med. 2005, 11:421-429.
83. Goronzy J.J., Lee W.W., Weyand C.M. Aging and T-cell diversity. Exp. Gerontol. 2007, 42:400-406.
84. Grabowska K., Hogberg L., Penttinen P., Svensson A., Ekdahl K. Occurrence of invasive pneumococcal disease and number of excess cases due to influenza. BMC Infect. Dis. 2006, 6:58.
85. Greenbaum J.A., Kotturi M.F., Kim Y., Oseroff C., Vaughan K., Salimi N., Vita R., Ponomarenko J., Scheuermann R.H., Sette A., Peters B. Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:20365-20370.
86. Grevers L.C., de Vries T.J., Vogl T., Abdollahi-Roodsaz S., Sloetjes A.W., Leenen P.J., Roth J., Everts V., van den Berg W.B., van Lent P.L. S100A8 Enhances osteoclastic bone resorption in vitro through activation of Toll-like receptor 4: implications for bone destruction in murine antigen-induced arthritis. Arthritis Rheum. 2011, 63:1365-1375.
87. Grewal T., Evans R., Rentero C., Tebar F., Cubells L., de Diego I., Kirchhoff M.F., Hughes W.E., Heeren J., Rye K.A., Rinninger F., Daly R.J., Pol A., Enrich C. Annexin A6 stimulates the membrane recruitment of p120GAP to modulate Ras and Raf-1 activity. Oncogene 2005, 24:5809-5820.
88. Hak E., Wei F., Nordin J., Mullooly J., Poblete S., Nichol L.L. Development and validation of a clinical prediction rule for hospitalization due to pneumonia or influenza or death during influenza epidemics among community-dwelling elderly persons. J. Infect. Dis. 2004, 189:450-458.
89. Hancock K., Veguilla V., Lu X., Zhong W., Butler E.N., Sun H., Liu F., Dong L., DeVos J.R., Gargiullo P.M., Brammer T.L., Cox N.J., Tumpey T.M., Katz J.M. Cross-reactive antibody responses to thepandemic H1N1 influenza virus. N. Engl. J. Med. 2009, 361:1945-1952.
90. Haq K., McElhaney J.E. Ageing and respiratory infections: the airway of ageing. Immunol. Lett. 2014, pii S 0165-2478.
91. Harris H.E., Raucci A. Alarmin(g) news about danger: workshop on innate danger signals and HMGB1. EMBO Rep. 2006, 7:774-778.
92. Hasegawa S., Matsushige T., Inoue H., Shirabe K., Fukano R., Ichiyama T. Serum and cerebrospinal fluid cytokine profile of patients with 2009 pandemic H1N1 influenza virus-associated encephalopathy. Cytokine 2011, 54:167-172.
93. Hauet-Broere F., Wieten L., Guichelaar T., Berlo S., van der Zee R., Van Eden W. Heat shock proteins induce T cell regulation of chronic inflammation. Ann. Rheum. Dis. 2006, 65(Suppl. III):iii65-iii68.
94. Hayflick L. The future of ageing. Nature 2000, 408:267-269.
95. Hedayat M., Takeda K., Rezaei N. Prophylactic and therapeutic implications of toll-like receptor ligands. Med. Res. Rev. 2012, 32:294-325.
96. Heng T.S.P., Goldberg G.L., Gray D.H.D., Sutherland J.S., Chidgey A.P., Boyd R.L. Effects of castration on thymocyte development in two different models of thymic involution. J. Immunol. 2005, 175(5):2982-2993.
97. Herbig U., Sedivy J.M. Regulation of growth arrest in senescence; telomere damage is not the end of the story. Mech. Aging Dev. 2006, 127:16-24.
98. Hernandez-Vargas E.A., Wilk E., Canini L., Toapanta F.R., Binder S., Uvarovskii A., Ross T.M., Carlos A., Guzman C.A., Perelson A.S., Meyer-Hermann M. The effects of aging on influenza virus infection dynamics. J. Virol. 2014, (in press). 10.1128/JVI.3644-13.
99. Hewitt G., Jurk D., Marques F.D.M., Correia-Melo C., Hardy T., Gackowska A., Anderson R., Taschuk M., Mann J., Passos J.F. Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat. Commun. 2012, 3:708.
100. Hifumi T., Jinbo I., Okada I., Kiriu N., Kato H., Koido Y., Inoue J., Kawakita K., Morita S., Kuroda Y. The impact of age on outcomes of elderly ED patients ventilated due to community acquired pneumonia. Am. J. Emerg. Med. 2015, 33(2):277-281.
101. Hiratsuka S., Watanabe A., Aburatani H., Maru Y. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat. Cell Biol. 2006, 8:1369-1375.
102. Hitchcock J.K., Katz A.A., Schafer G. Dynamic reciprocity: the role of annexin A2 in tissue integrity. J. Cell Commun. Signal. 2014, 8:125-133.
103. Holsinger L.J., Nichani D., Pinto L.H., Lamb R.A. Influenza A virus M2 ion channel protein: a structure-function analysis. J. Virol. 1994, 68:1551-1563.
104. Hou X.Q., Qin J.L., Zheng X.X., Wang L., Yang S.T., Gao Y.W., Xia X.Z. Potential role of high-mobility group box 1 protein in the pathogenesis of influenza H5N1 virus infection. Acta Virol. 2014, 58:69-75.
105. Hoyaux D., Decaestecker C., Heizmann C.W., Vogl T., Schafer B.W., Salmon I., Kiss R., Pochet R. S100 proteins in Corpora amylacea from normal human brain. Brain Res. 2000, 867:280-288.
106. Huang R.T., Lichtenberg B., Rick O. Involvement of annexin V in the entry of influenza viruses and role of phospholipids in infection. FEBS Lett 1996, 392:59-62.
107. Huttunen H.J., Rauvala H. Amphoterin as an extracellular regulator of cell motility: from discovery to disease. J. Intern. Med. 2004, 255:351-366.
108. Ichinohe T., Lee H.K., Ogura Y., Flavell R., Iwasaki A. Inflammasome recognition of influenza virus is essential for adaptive immune responses. J. Exp. Med. 2009, 206:79-87.
109. Ichinohe T., Pang I.K., Iwasaki A. Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nat. Immunol. 2010, 11:404-410.
110. Ison M.G., Hirsch H.H. Influenza: a recurrent challenge to transplantation. Transpl. Infect. Dis. 2010, 12:95-97.
111. Iwasaki A., Pillai P.S. Innate immunity to influenza virus infection. Nat. Rev. Immunol. 2014, 14:315-328.
112. Izurieta H.S., Thompson W.W., Kramarz P., Shay D.K., Davis R.L., DeStefano F., Black S., Shinefields H., Fukuda K. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N. Engl. J. Med. 2000, 342:232-239.
113. Jackaman C., Radley-Crabb H.G., Soffe Z., Shavlakadze T., Grounds M.D., Nelson D.J. Targeting macrophages rescues age-related immune deficiencies in C57BL/6J geriatric mice. Aging Cell 2013, 12:345-357.
114. Jain S., Kamimoto L., Bramley A.M., Schmitz A.M., Benoit S.R., Louie J., Sugerman D.E., Druckenmiller J.K., Ritger K.A., Chugh R., Jasuja S., Deutscher M., Chen S., Walker J.D., Duchin J.S., Lett S., Soliva S., Wells E.V., Swerdlow D., Uyeki T.M., Fiore A.E., Olsen S.J., Fry A.M., Bridges C.B., Finelli L. Hospitalized patients with 1N1 influenza in the United States, April-June 2009. N. Engl. J. Med. 2009, 361:1935-1944.
115. Jefferson T., Deeks J.J., Demicheli V., Rivetti D., Rudin M. Amantadine and rimantadine for preventing and treating influenza A in adults. Cochrane Database Syst. Rev. 2004, CD001169.
116. Jefferson T., Jones M., Doshi P., Spencer E.A., Onakpoya I., Heneghan C.J. Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments. BMJ 2014, 348:g2545.
117. Jiang H., Schiffer E., Song Z., Wang J., Zurbig P., Thedieck K., Moes S., Bantel H., Saal N., Jantos J., Brecht M., Jeno P., Hall M.N., Hager K., Manns M.P., Hecker H., Ganser A., Dohner K., Bartke A., Meissner C., Mischak H., Ju Z., Rudolph K.L. Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and disease. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:11299-11304.
118. Joseph C., Togawa Y., Shindo N. Bacterial and viral infections associated with influenza. Influenza Other Respir. Viruses 2013, 7(Suppl. 2):105-113.
119. Jurk D., Wilson C., Passos J.F., Oakley F., Correia-Melo C., Greaves L., Saretzki G., Saretzki G., Fox C., Lawless C., Anderson R., Hewitt G., Pender S.L.F., Fullard N., Nelson G., Mann J., Sluis B., Mann D.A., Zglinicki T. Chronic inflammation induces telomere dysfunction and accelerates ageing in mice. Nat. Commun. 2014, 5(4172):1-14.
120. Kang J.H. Effectiveness and safety of seasonal influenza vaccination in children with underlying respiratory diseases and allergy. Korean J. Pediatr. 2014, 57:164-170.
121. Kanneganti T.D., Body-Malapel M., Amer A., Park J.H., Whitfield J., Frachi L., Taraporewala Z.F., Miller D., Patton J.T., Inohara N., Nunez G. Critical role for cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J. Biol. Chem. 2006, 281:36560-36568.
122. Kaplan V., Angus D.C., Griffin M.F., Clermont G., Scott W.R., Linde-Zwirble W.T. Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am. J. Respir. Crit. Care Med. 2002, 165(6):766-772.
123. Kaspar A.A., Okada S., Kumar J., Poulain F.R., Drouvalakis K.A., Kelekar A., Hanson D.A., Kluck R.M., Hitoshi Y., Johnson D.E., Froelich C.J., Thompson C.B., Newmeyer D.D., Anel A., Clayberger C., Krensky A.M.A. Distinct pathway of cell-mediated apoptosis initiated by granulysin. J. Immunol. 2001, 167:350-356.
124. Kassam G., Choi K.S., Ghuman J., Kang H.M., Fitzpatrick S.L., Zackson T., Zackson S., Toba M., Shinomiya A., Waisman D.M. The role of annexin II tetramer in the activation of plasminogen. J. Biol. Chem. 1998, 273:4790-4799.
125. Kataoka H., Kono H., Patel Z., Rock K.L. Evaluation of the contribution of multiple DAMPs and DAMP receptors in cell death-induced sterile inflammatory responses. PLoS One 2014, 9:e104741.
126. Kawada J., Kimura H., Ito Y., Hara S., Iriyama M., Yoshikawa T., Morishima T. Systemic cytokine responses in patients with influenza-associated encephalopathy. J. Infect. Dis. 2003, 188:690-698.
127. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat. Immunol. 2010, 11:373-384.
128. Kawanishi S., Oikawa S. Mechanism of telomere shortening by oxidative stress. Ann. N. Y. Acad. Sci. 2004, 1019:278-284.
129. Kawasaki T., Kawai T. Toll-like receptor signaling pathways. Front. Immunol. 2014, 25:461.
130. Kim J., Adam R.M., Freeman M.R. Activation of the Erk mitogen-activated protein kinase pathway stimulates neuroendocrine differentiation in LNCaP cells independently of cell cycle withdrawal and STAT3 phosphorylation. Cancer Res. 2002, 62:1549-1554.
131. Kirpotina L.N., Khlebnikov A.I., Schepetkin I.A., Ye R.D., Rabiet M., Jutila M.A., Quinn M.T. Identification of novel small-molecule agonists for human formyl peptide receptors and pharmacophore models of their recognition. Mol. Pharmacol. 2010, 77:159-170.
132. Klepser M.E. Socioeconomic impact of seasonal (epidemic) influenza and the role of over-the-counter medicines. Drugs 2014, 74:1467-1479.
133. Klune J.R., Dhupar R., Cardinal J., Billiar T.R., Tsung A. HMGB1: endogenous danger signaling. Mol. Med. 2008, 14:476-484.
134. Kokkola R., Andersson A., Mullins G., Ostberg T., Treutiger C.J., Arnold B., Nawroth P., Andersson U., Harris R.A., Harris H.E. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand. J. Immunol. 2005, 61:1-9.
135. Kosai K., Seki M., Yanagihara K., Nakamura S., Kurihara S., Izumikawa K., Kakeya H., Yamamoto Y., Tashiro T., Kohno S. Elevated levels of high mobility group box chromosomal protein-1 (HMGB-1) in sera from patients with severe bacterial pneumonia coinfected with influenza virus. Scand. J. Infect. Dis. 2008, 40:338-342.
136. Kruk P.A., Rampino N.J., Bohr V.A. DNA damage and repair in telomeres: relation to aging. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:258-262.
137. Krysko O., Løve Aaes T., Bachert C., Vandenabeele P., Krysko D.V. Many faces of DAMPs in cancer therapy. Citation: Cell Death Dis. 2013, 4:e631.
138. Kumar D., Michaels M.G., Morris M.I., Green M., Avery R.K., Liu C., Danziger-Isakov L., Store V., Estabrook M., Gantt S., Marr K.A., Martin S., Silveira F.P., Razonable R.R., Allen U.D., Levi M.E., Lyon G.M., Bell L.E., Huprikar S., Patel G., Gregg K.S., Pursell K., Helmersen D., Julian K.G., Shiley K., Bono B., Dharnidharka V.R., Alavi G., Kalpoe J.S., Shoham S., Reid G.E. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect. Dis. 2010, 10:521-526.
139. Kumar H., Kawai T., Akira S. Pathogen recognition by the innate immune system. Int. Rev. Immunol. 2011, 30:16-34.
140. Kummer M.P., Vogl T., Axt D., Griep A., Vieira-Saecker A., Jessen F., Gelpi E., Roth J., Heneka M.T. Mrp14 deficiency ameliorates amyloid β burden by increasing microglial phagocytosis and modulation of amyloid precursor protein processing. J. Neurosci. 2012, 32:17824-17829.
141. Kuribayashi S., Sakoda Y., Kawasaki T., Tanaka T., Yamamoto N., Okamatsu M., Isoda N., Tsuda Y., Sunden Y., Umemura T., Nakajima N., Hasegawa H., Kida H. Excessive cytokine response to rapid proliferation of highly pathogenic avian influenza viruses leads to fatal systemic capillary leakage in Chickens. PLoS One 2013, 8:e68375.
142. Kwon M., MacLeod T.J., Zhang Y., Waisman D.M. S100A, annexin A2, and annexin A2 heterotetramer as candidate plasminogen receptors. Front. Biosci. 2005, 10:300-325.
143. Lai C., Wang X., Yang P. Cytokines Network and Influenza Virus Infection. Clin. Microb. 2014, 3. 10.4172/2327-5073.10001473.
144. Lambert N.D., Ovsyannikova I.G., Pankratz V.S., Jacobson R.M., Poland G.A. Understanding the immune response to seasonal influenza vaccination in older adults: a systems biology approach. Expert Rev. Vaccines 2012, 11:985-994.
145. Lanzer K.G., Johnson L.L., Woodland D.L., Blockman M.A. Impact of ageing on the response and repertoire of influenza virus-specific CD4 T cells. Immun. Ageing 2014, 11:9.
146. LeBouder F., Lina B., Rimmelzwaan G.F., Riteau B.J. Plasminogen promotes influenza A virus replication through an annexin 2-dependent pathway in the absence of neuraminidase. Gen. Virol. 2010, 91:2753-2761.
147. LeBouder F., Morello E., Rimmelzwaan G.F., Bosse F., Péchoux C., Delmas B., Riteau B. Annexin II incorporated into influenza virus particles supports virus replication by converting plasminogen into plasmin. J. Virol. 2008, 82:6820-6828.
148. Lee N., Shin M.S., Kang I. T- biology in aging, with a focus on lung disease. J. Gerontol. Ser. A, Biol. Sci. Med. Sci. 2012, 67:254-263.
149. Lee N., Wong C.K., Hui D.S.C., Lee S.K.W., Wong R.Y.K., Ngai K.L.K., et al. Role of human toll-like receptors in naturally occurring influenza a infections. Influenza Other Respir. Viruses 2013, 7:666-675.
150. Lee S.M.Y., Kok K.H., Jaume M., Cheung T.K.W., Yip T., Lai J.C.C., Guan Y., Webster R.G., Jin D., Malik Peiris J.S. Toll-like receptor 10 is involved in induction of innate immune responses to influenza virus infection. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:3793-3798.
151. Lemaitre M., Meret T., Rothan-Tondeur M., Belmin J., Lejonc J.L., Luguel L., Piette F., Salom M., Verny M., Vetel J.M., Veyssier P., Carrat F. Effect of influenza vaccination of nursing home staff on mortality of residents: a cluster-randomized trial. J. Am. Geriatr. Soc. 2009, 57:15801-15806.
152. Leukert N., Vogl T., Strupat K., Reichelt R., Sorg C., Roth J. Calcium-dependent tetramer formation of S100A8 and S100A9 is essential for biological activity. J. Mol. Biol. 2006, 16(359):961-972.
153. Li J., Kokkola R., Tabibzadeh S., Yang R., Ochani M., Qiang X., Harris H.E., Czura C.J., Wang H., Ulloa L., Wang H., Shaw Warren H., Moldawer L.L., Fink M.P., Andersson U., Tracey K.J., Yang H. Structural basis for the proinflammatory cytokine activity of high mobility group box 1. Mol. Med. 2003, 9:37-45.
154. Li P., Zhang J.F., Xia X.D., Su D.J., Liu B.L., Zhao D.L., Liu Y., Zhao D.H. Serial evaluation of high-resolution CT findings in patients with pneumonia in novel swine-origin influenza A (H1N1) virus infection. Br. J. Radiol. 2012, 85:729-735.
155. Liao C., Chang S., Chen S., Chio C. Influenza-associated morbidity in subtropical Taiwan. Int. J. Infect. Dis. 2009, 13:589-599.
156. Liew A.A., Narasaraju T., Phoon M.C., Wang S., Tan K.B., Chow T. Caspase-1-deficient mice are more susceptible than wild-type mice to pneumonia induced by influenza A (H1N1). Eur. J. Inflammation 2014, 12:117-130.
157. Lindau D., Roĵnnefarth V., Erbacher A., Rammensee H., Decker P. Nucleosome-induced neutrophil activation occurs independently of TLR9 and endosomal acidification: implications for systemic lupus erythematosus. Eur. J. Immunol. 2011, 41:669-681.
158. Liu W.M., van der Zeijst B.A.M., Boog C.J., Soethout E.C. Aging and impaired immunity to influenza viruses: Implications for vaccine development. Hum. Vaccines 2011, 7:94-98.
159. Lizarbe M.A., Barrasa J.I., Olmo N., Gavilanes F., Turnay J. Annexin-phospholipid interactions. Functional implications. Int. J. Mol. Sci. 2013, 14:2652-2683.
160. Lopez-Medrano F., Aguado J.M., Lizasoain M., Folgueira D., Juan R.S., Diaz-Pedroche C., Lumbreras C., Morales J.M., Delgado J.F., Moreno-Gonzalez E. Clinical implications of respiratory virus infections in solid organ transplant recipients: a prospective study. Transplantation 2007, 84:851-856.
161. Lotze M.T., Tracey K.J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 2005, 5:331-342.
162. Lund J.M., Alexopoulou L., Sato A., Karow M., Adams N.C., Gale N.W., Iwasaki A., Flavell R.A. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:5598-5603.
163. Lynch H.E., Goldberg G.L., Chidgey A., Van den Brink M.R., Boyd R., Sempowski G.D. Thymic involution and immune reconstitution. Trends Immunol. 2009, 30:366-373.
164. Ma H., Kien F., Manière M., Zhang Y., Lagarde N., Tse K.S., Poon L.L., Nal B. Human annexin A6 interacts with influenza a virus protein M2 and negatively modulates infection. J. Virol. 2012, 86(3):1789-1801.
165. Ma W., Liu Q., Qiao C., del Real G., Adolfo García-Sastre A., Webby R.J., Jürgen A., Richt J.A. North American triple reassortant and eurasian H1N1 swine influenza viruses do not readily reassort to generate a 2009 pandemic H1N1-like virus. MBoi 2014, 5. e00919-13.
166. Madureira P.A., Surette A.P., Phipps K.D., Taboski M.A., Miller V.A., Waisman D.M. The role of the annexin A2 heterotetramer in vascular fibrinolysis. Blood 2011, 118(18):4789-4797.
167. Maines T.R., Szretter K.J., Perrone L., Belser J.A., Bright R.A., Zeng H., Tumpey T.M., Katz J.M. Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response. Immunol. Rev. 2008, 225:68-84.
168. Mariathasan S., Monack D.M. Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat. Rev. Immunol. 2008, 7:31-40.
169. Matsuyama Y., Okazaki H., Tamemoto H., Kimura H., Kamata Y., Nagatani K., Hayakawa M., Iwamoto M., Yoshio T., Tominaga S., Minota S. Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis. J. Rheumatol. 2010, 37:18-25.
170. McAuley J.L., Tate M.D., MacKenzie-Kludas C.J., Pinar A., Zeng W., Stutz A., Latz E., Brown L.E., Mansell E. Activation of the NLRP3 inflammasome by IAV virulence protein PB1-F2 contributes to severe pathophysiology and disease. PLoS Pathog 2013, 9:e1003392.
171. McCarthy D.A., Ranganathan A., Subbaram S., Flaherty N.L., Patel N., Trebak M., Hempel N., Melendez J.A. Redox-control of the alarmin, interleukin-1α. Redox Biol. 2013, 1:218-225.
172. McCullers J.A. Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza. J. Infect. Dis. 2004, 190:519-526.
173. McCullers J.A., Bartmess K.C. Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J. Infect. Dis. 2003, 187:1000-1009.
174. McDonald B., Pittman K., Menezes G.B., Hirota S.A., Slaba I., et al. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 2010, 330:362-366.
175. McElhaney J.E., Xie D., Hager W.D., Barry M.B., Wang Y., Kleppinger A., Ewen C., Kane K.P., Bleackley R.C. T cell responses are better correlates of vaccine protection in the elderly. J. Immunol. 2006, 176:6333-6339.
176. McKanna J.A. Lipocortin 1 in apoptosis: mammary regression. Anat. Rec. 1995, 242:1-10.
177. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007, 449:819-826.
178. Messmer D., Yang H., Telusma G., Knoll F., Li J., Messmer B., Tracey K.J., Chiorazzi N. High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization. J. Immunol. 2004, 173:307-313.
179. Moisy D., Avilov A.V., Jacob Y., Laoide B.M., Ge X., Baudin F., Naffakh N., Jestin J. HMGB1 protein binds to influenza virus nucleoprotein and promotes viral replication. J. Virol. 2015, 17:9122-9133.
180. Mok M.Y., Huang F.P., Ip W.K., Lo Y., Wong F.Y., Chan E.Y., Lam K.F., Xu D. Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus. Rheumatology 2010, 49:520-527.
181. Molinari N.A.M., Ortega-Sanchez I.R., Messonnier M.I., Thompson W.W., Wortley P.M., Weintraub E., Bridges C.B. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007, 25:5086-5096.
182. Mora A.L., Rojas M. Aging and lung injury repair: a role for bone marrow derived mesenchymal stem cells. J. Cell. Biochem. 2008, 105:641-647.
183. Moran G.J., Rothman R.E., Volturo G.A. Emergency management of community-acquired bacterial pneumonia: what is new since the 2007 Infectious Diseases Society of America/American Thoracic Society guidelines. Am. J. Emerg. Med. 2013, 31:602-612.
184. Moreno A., Di Trani L., Faccini S., Vaccari G., Nigrelli D., Boniotti M.B., Falcone E., Boni A., Chiapponi C., Sozzi E., Cordioli P. Novel H1N2 swine influenza reassortant strain in pigs derived from the pandemic H1N1/2009 virus. Vet. Microbiol. 2011, 149:472-477.
185. Murasko D.M., Jiang J. Response of aged mice to primary virus infections. Immunol. Rev. 2005, 205:285-296.
186. Murata Y., Walsh E.E., Falsey A.R. Pulmonary complications of inter- pandemic influenza A in hospitalized adults. J. Infect. Dis. 2007, 195:1029-1037.
187. Musiol A., Gran S., Ehrhardt C., Ludwig S., Grewal T., Gerke V., Rescher U. Annexin A6-balanced late endosomal cholesterol controls influenza A replication and propagation. MBio 2013, 4:e00608-e00613.
188. Nagel J.E., Chopra R.K., Powers D.C., Adler W.H. Effect of age on the human high affinity interleukin 2 receptor of phytohaemagglutinin stimulated peripheral blood lymphocytes. Clin. Exp. Immunol. 1989, 75:286.
189. Nalapareddy K., Jiang H., Guachalla Gutierrez L.M., Rudolph K.L. Determining the influence of telomere dysfunction and DNA damage on stem and progenitor cell aging: what markers can we use?. Exp. Gerontol. 2008, 43:998-1004.
190. Narasaraju T., Yang E., Samy R.P., Ng H.H., Poh W.P., Liew A.A., Phoon M.C., van Rooijen N., Chow V.T. Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am. J. Pathol. 2011, 179:199-210.
191. Nawa Y., Kawahara K., Tancharoen S., Meng X., Sameshima H., Ito T., Masuda Y., Imaizumi H., Hashiguchi T., Maruyama I. Nucleophosmin may act as an alarmin: implications for severe sepsis. J. Leukoc. Biol. 2009, 86:1-8.
192. Nelson M.I., Gramer M.R., Vincent A.L., Holmes E.C. Global transmission of influenza viruses from humans to swine. J. Gen. Virol. 2012, 93:2195-2203.
193. Neralla S., Meyer K.C. Drug treatment of pneumococcal pneumonia in the elderly. Drugs Aging 2004, 21(13):851-864.
194. Neumann G., Noda T., Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 2009, 59:931-939.
195. Neuzil K.M., Reed G.W., Mitchel E.F., Simonsen L., Griffin M.R. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am. J. Epidemiol. 1998, 148:1094-1102.
196. Nikolich-Zugich J. Age-associated T-cell clonal expansions (TCE) in vivo- implications for pathogen resistance: cellular immunosenescence T cells. Handbook on Immunosenescence: Basic Understanding and Clinical Applications 2009, 219-233. Springer, The Netherlands.
197. Nikolich-Zugich J., Li G., Uhrlaub J.L., Renkema K.R., Smithey M.J. Age-related changes in CD8 T cell homeostasis and immunity to infection. Immunology 2012, 24:356-364.
198. Nogueira-Machado J.A., de Oliveira Volpe C.M. HMGB-1 as a target for inflammation controlling. Recent Pat Endocr. Metab. Immune Drug Discov. 2012, 6:201-209.
199. Nosaka N., Yashiro M., Yamada M., Fujii Y., Tsukahara H., Liu K., Nishibori M., Matsukawa A., Morishima T. Anti-high mobility group box-1 monoclonal antibody treatment provides protection against influenza A virus (H1N1)-induced pneumonia in mice. Crit. Care 2015, 19:249.
200. Oikawa S., Tada-Oikawa S., Kawanishi S. Site-specific DNA damage at the GGG sequence by UVA involves acceleration of telomere shortening. Biochemistry 2001, 40:4763-4768.
201. Olivieri F., Rita Rippo M., Prattichizzo F., Graciotti L., Domenico Procopio A. Toll like receptor signaling in inflammaging: microRNA as new players. Immun. Ageing 2013, 10:11. 10.1186/1742-4933-10-11.
202. Oppenheim J.J., Yang D. Alarmins: chemotactic activators of immune responses. Curr. Opin. Immunol. 2005, 17:359-365.
203. Otto M., Günther A., Fan H., Rick O., Huang R.T. Identification of annexin 33kDa in cultured cells as a binding protein of influenza viruses. FEBS Lett. 1994, 356:125-129.
204. Owen D.M., Gale M. Fighting the flu with inflammasome signaling. Immunity 2009, 30:476-478.
205. Panda A., Qian F., Mohanty S., van Duin D., Newman F.K., Zhang L., Chen S., Towle V., Belshe R.B., Fikrig E., Allore H.G., Montgomery R.R., Shaw A.C. Age-associated decrease in TLR function in primary humandendritic cells predicts influenza vaccine response. J. Immunol. 2010, 184:2518-2527.
206. Passos J.F., Nelson G., Wang C., Richter T., Simillion C., Proctor C.J., Miwa S., Olijslagers S., Hallinan J., Wipat A., Saretzki G., Rudolph K.L., Kirkwood T.B., von Zglinicki T. Feedback between p21 and reactive oxygen production is necessary for cell senescence. Mol. Syst. Biol. 2010, 6:347.
207. Pawelec G. Immunosenescence comes of age. Symposium on aging research in immunology: the impact of genomics. EMBO Rep. 2007, 8:220-223.
208. Pawelec G., Larbi A. Immunity and ageing in man: annual review 2006/2007. Exp. Gerontol. 2008, 43:34-38.
209. Peiris J.S., Cheung C.Y., Leung C.Y., Nicholls J.M. Innate immune responses to influenza A H5N1: friend or foe. Trends Immunol. 2009, 30:574-584.
210. Petrilli V., Papin S., Dostert C., Mayor A., Martinon F., Tschopp J. Activation ofthe NALP3 inflammasomeis triggered by low intracellular potassium concentration. Cell Death Differ. 2007, 14:1583-1589.
211. Pettigrew M.M., Gent J.F., Pyles R.B., Miller A.L., Nokso-Koivisto J., Chonmaitree T. Viral-bacterial interactions and risk of acute otitis media complicating upper respiratory tract infection. J. Clin. Microbiol 2011, 49(11):3750-3755.
212. Peuscher M.H., Jacobs J.J. DNA-damage response and repair activities at uncapped telomeres depend on RNF8. Nat. Cell Biol. 2011, 13:1139-1145.
213. Peuscher M.H., Jacobs J.J. Posttranslational control of telomere maintenance and the telomere damage response. Cell Cycle 2012, 11:1524-1534.
214. Pinto L.H., Lamb R.A. The M2 proton channels of influenza A and B viruses. J. Biol. Chem. 2006, 281:8997-9000.
215. Rang Franka J., Boonstra J. Causes and consequences of age-related changes in DNA methylation: A role for ROS?. Biology 2014, 3:2079-7737. p403.
216. Ravasi T., Hsu K., Goyette J., Schroder K., Yang Z., Rahimi F., Miranda L.P., Alewood P.F., Hume D.A., Geczy C. Probing the S100 protein family through genomic and functional analysis. Genomics 2004, 84:10-22.
217. Rehwinkel J. Exposing viruses: RNA patterns sensed by RIG-I-like receptors. J. Clin. Immunol. 2010, 30:491-495.
218. Rehwinkel J., Tan C.P., Goubau D., Schulz O., Pichlmair A., Bier K., Rob N., Vreede F., Barclay W., Fodor E., Reis e Sousa C. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 2010, 140:397-408.
219. Renshaw M., Rockwell J., Engleman C., Gewirtz A., Katz J., Sambhara S. Cutting edge: impaired toll-like receptor expression and function in aging. J. Immunol. 2002, 169:4697-4701.
220. Rescher U., Gerke V. S100A10/p11: family, friends and functions. Pflugers Arch. 2008, 455:575-582.
221. Réty S., Sopkova J., Renouard M., Osterloh D., Gerke V., Tabaries S., Russo-Marie F., Lewit-Bentley A. The crystal structure of a complex of p11 with the annexin II N-terminal peptide. Nat. Struct. Biol. 1999, 6:89-95.
222. -/- mice. J. Virol. 2000, 74:9762.
223. Rock K.L., Latz E., Ontiveros F., Kono H. The sterile inflammatory response. Annu. Rev. Immunol. 2010, 28:321-342.
224. Rodier F., Coppe J.P., Patil C.K., Hoeijmakers W.A.M., Munoz D.P., Raza S.R., Freund A., Campeau E., Davalos A.R., Campisi J. Persistent DNA damage signalling triggers senescence associated inflammatory cytokine secretion. Nat. Cell Biol. 2009, 11:973-979.
225. Rothberg M.B., Haessler S.D., Brown R.B. Complications of viral influenza. Am. J. Med. 2008, 121:258-264.
226. Rudd B.D., Venturi V., Davenport M.P., Nikolich-Zugich J. Evolution of the antigen-specific CD8+ TCR repertoire across the life span: evidence for clonal homogenization of the old TCR repertoire. J. Immunol. 2011, 186:2056-2064.
227. Sakaguchi T., Leser G.P., Lamb R.A. The ion channel activity of the influenza virus M2 protein affects transport through the Golgi apparatus. J. Cell Biol. 1996, 133:733-747.
228. Sakwe A.M., Koumangoye R., Guillory B., Ochieng J. Annexin A6 contributes to the invasiveness of breast carcinoma cells by influencing the organization and localization of functional focal adhesions. Exp. Cell Res. 2011, 317:823-837.
229. Salama I., Malone P.S., Mihaimeed F., Jones J.L. A review of the S100 proteins in cancer. Eur. J. Surg. Oncol. 2008, 34:357-364.
230. Salminen A., Kaarniranta K., Kauppinen A. Inflammaging: disturbed interplay between autophagy and inflammasomes. Aging (Milano) 2012, 4:166-175.
231. Salomon B., Bluestone J.A. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 2001, 19:225-252.
232. - T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J. Immunol. 2002, 168:5893.
233. Scaffidi P., Misteli T., Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418:191-195.
234. Schulz D.M., Kalkhof S., Schmidt A., Ihling C., Stingl C., Mechtler K., Zschörnig O., Sinz A. Annexin A2/P11 interaction: new insights into annexin A2 tetramer structure by chemical crosslinking, high-resolution mass spectrometry, and computational modeling. Proteins 2007, 69:254-269.
235. Scott P., Ma H., Viriyakosol S., Terkeltaub R., Liu-Bryan R. Engagement of CD14 mediates the inflammatory potential of monosodium urate crystals. J. Immunol. 2006, 177:6370-6378.
236. Seropian I.M., Cerliani J.P., Toldo S., van Tassell B.W. Galectin-1 controls cardiac inflammation and ventricular remodeling during acute myocardial infarction. Am. J. Pathol. 2013, 182:2940.
237. Shaw A.C., Joshi S., Greenwood H., Panda A., Lord J.M. Aging of the innate immune system. Curr. Opin. Immunol. 2010, 22:507-513.
238. Shirey K.A., Lai W., Scott A.J., Lipsky M., Mistry P., Pletneva L.M., Karp C.L., McAlees J., Gioannini T.L., Weiss J., Chen W.H., Ernst R.K., Rossignol D.P., Gusovsky F., Blanco J.C., Vogel S.N. The TLR4 antagonist Eritoran protects mice from lethal influenza infection. Nature 2013, 497:498-502.
239. Simonsen L., Taylor R.J., Viboud C., Miller M.A., Jackson L.A. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect. Dis. 2007, 7(10):658-666.
240. Singh T., Newman A.B. Inflammatory markers in population studies of aging. Ageing Res. Rev. 2011, 10:319-329.
241. Singh V., Sharma B.B., Patel V. Pulmonary sequelae in a patient recovered from swine flu. Lung India: Off. Organ Indian Chest Soc. 2012, 29:277-279.
242. Smithey M.J., Li G., Venturi V., Davenport M.P., Nikolich-Zugich J. Lifelong persistent viral infection alters the naive T cell pool, impairing CD8 T cell immunity in late life. J. Immunol. 2012, 189:5356-5366.
243. Sohal R.S., Weindruch R. Oxidative stress, caloric restriction, and aging. Science 1996, 273:59-63.
244. Stout-Delgado H.W., Vaughan S.E., Shirali A.C., Jaramillo R.J., Harrod K.S. Impaired NLRP3 inflammasome function in elderly mice during influenza infection is rescued by treatment with nigericin. J. Immunol. 2012, 188:2815-2824.
245. Streicher W.W., Lopez M.M., Makhatadze G.I. Annexin I and annexin II N-terminal peptides binding to S100 protein family members: specificity and thermodynamic characterization. Biochemistry 2009, 48:2788-2798.
246. Strindhall J., Nilsson B.O., Lofgren S., Ernerudh J., Pawelec G., Johansson B., Wikby A. No immune risk profile among individuals who reach 100 years of age: findings from the Swedish NONA immune longitudinal study. Exp. Gerontol. 2007, 42:753-761.
247. Suh M., Kang D.R., Lee D.H., Choi Y.J., Tchoe B., Nam C.M., Kim J., Lee J.K., Jun B.Y., Youm Y., Bae G., Lee T.Y., Kim M.S., Shin D.C., Kim C. Socioeconomic burden of influenza in the Republic of Korea, 2007-2010. PLoS One 2013, 8:e84121.
248. Swindell W.R., Johnston A., Xing X., Little A., Robichaud P., Voorhees J.J., Fisher G., Gudjonsson J.E. Robust shifts in S100a9 expression with aging: a novel mechanism for chronic inflammation. Sci. Rep. 2013, 3(1215). 10.1038/srep01215.
249. Swisher J.F., Khatri U., Feldman G.M. Annexin A2 is a soluble mediator of macrophage activation. J. Leukoc. Biol. 2007, 82:1174-1184.
250. Swisher J.F.A., Burton N., Bacot S.M., Vogel S.N., Feldman G.M. Annexin A2 tetramer activates human and murine macrophages through TLR4. Blood 2010, 115:549-558.
251. Szucs T. The socio-economic burden of influenza. J. Antimicrob. Chemother. 1999, 44(Suppl. B2):11-15.
252. Takeda K., Akira S. Toll-like receptors in innate immunity. Int. Immunol. 2005, 17:1-14.
253. Takeda M., Pekosz A., Shuck K., Pinto L.H., Lamb R.A. Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture. J. Virol. 2002, 76:1391-1399.
254. Takeuchi O., Akira S. Innate immunity to virus infection. Immunol. Rev. 2009, 227:75-86.
255. Tang E.D., Wang C.Y. TRAF is a downstream target of MAVS in antiviral innate immune signaling. PLoS One 2010, 5:e9172.
256. Thomas P.G., Dash P., Aldridge J.R., Ellebedy A.H., Reynolds C., Funk A.J., Martin W.J., Lamkanfi M., Webby R.J., Boyd K.L., Doherty P.C., Kanneganti T.D. The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity 2009, 30:566-575.
257. Thomas P.G., Dash P., Aldridge J.R., Ellebedy A.H., Reynolds C., Funk A.J., Martin W.J., Lamkanfi M., Webby R.J., Boyd K.L., Doherty P.C., Kanneganti T.D. The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity 2009, 30:566-575.
258. Thompson W.W., Shay D.K., Weinratub E., Brammer L., Bridges C.B., Cox N.J., Fududa K. Influenza-associated hospitalizations in the United States. JAMA 2004, 292:1333-1340.
259. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289:179-186.
260. Toapanta F.R., Ross T.M. Impaired immune responses in the lungs of aged mice following influenza infection. Respir. Res. 2009, 10:1-19.
261. Toschke A.M., Heuschmann P.U., Wood O., Wolfe C.D.A. Temporal relationship between influenza infections and subsequent first-ever stroke incidence. Age Ageing 2009, 38:100-103.
262. Tsai S.Y., Segovia J.A., Chang T.H., Morris I.R., Berton M.T., Tessier P.A., Tardif M.R., Cesaro A., Bose S. DAMP molecule S100A9 acts as a molecular pattern to enhance inflammation during influenza A virus infection: role of DDX21-TRIF-TLR4-MyD88 pathway. PLoS Pathog 2014, 10:e1003848.
263. Umeda Y., Morikawa M., Anzai M., Sumida Y., Kadowaki M., Ameshima S., Ishizki T. Acute exacerbation of idiopathic pulmonary fibrosis after pandemic influenza A (H1N1) vaccination. Intern. Med. 2010, 49:2333-2336.
264. van Attikum H., Gasser S.M. Crosstalk between histone modifications during the DNA damage response. Trends Cell Biol. 2009, 19:207-217.
265. van Beijnum J.R., Buurman W.A., Griffioen A.W. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis 2008, 11:91-99.
266. van Lent P.L., Grevers L., Blom A.B., Sloetjes A., Mort J.S., Vogl T., Nacken W., van den Berg W.B., Roth J. Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis. Ann. Rheum. Dis. 2008, 67:1750-1758.
267. Van Reeth K., Van Gucht S., Pensaert M. Correlations between lung proinflammatory cytokine levels, virus replication, and disease after swine influenza virus challenge of vaccination-immune pigs. Viral Immunol. 2002, 15:583-594.
268. Vasto S., Candore G., Balistreri C.R., Caruso M., Colonna-Romano G., Grimaldi M.P., Listi F., Nuzzo D., Lio D., Caruso C. Inflammatory networks in ageing, age-related diseases and longevity. Mech. Ageing Dev. 2007, 128:83-91.
269. Vasto S., Colonna-Romano G., Larbi A., Wikby A., Caruso C., Pawelec G. Role of persistent CMV infection in configuring T cell immunity in the elderly. Immun. Ageing 2007, 4:2. 10.1186/1742-4933-4-2.
270. Vasto S., Carruba G., Lio D., Colonna-Romano G., Di Bona D., Candore G., Caruso C. Inflammation, ageing and cancer. Mech. Ageing Dev. 2009, 130:40-45.
271. Viboud C., Boelle P.Y., Cauchemez S., Lavenu A., Valleron A.J., Flahault A., Carrat F. Risk factors of influenza transmission in households. Br. J. Gen. Pract. 2004, 54:684-689.
272. Vijaykrishna D., Poon L.L., Zhu H.C., Ma S.K., Li O.T., Cheung C.L., Smith G.J., Peiris J.S., Guan Y. Reassortment of pandemic H1N1/2009 influenza A virus in swine. Science 2010, 328:1529.
273. Viláde Muga S., Timpson P., Cubells L., Evans R., Hayes T.E., Rentero C., Hegemann A., Reverter M., Leschner J., Pol A., Tebar F., Daly R.J., Enrich C., Grewal T. Annexin A6 inhibits Ras signalling in breast cancer cells. Oncogene 2009, 28:363-377.
274. Vogl T., Eisenblatter M., Voller T., Zenker S., Hermann S., van Lent P., Faust A., Geyer C., Petersen B., Roebrock K., Schafers M., Bremer C., Roth J. Alarmin S100A8/S100A9 as a biomarker for molecular imaging of local inflammatory activity. Nat. Commun. 2014, 5(4593):1-12.
275. Vogl T., Gharibyan A.L., Morozova-Roche L.A. Pro-inflammatory S100A8 and S100A9 proteins: self-assembly into multifunctional native and amyloid complexes. Int. J. Mol. Sci. 2012, 13:2893-2917.
276. Walker C.L., Rudan I., Liu L., Nair H., Theodoratou E., Bhutta Z.A., O'Brien K.L., Campbell H., Black R.E. Global burden of childhood pneumonia and diarrhoea. Lancet 2013, 381:1405-1416.
277. Wang C., Klechikov A.G., Gharibyan A.L., Wärmländer S.K., Jarvet J., Zhao L., Jia X., Narayana V.K., Shankar S.K., Olofsson A., Brännström T., Mu Y., Gräslund A., Morozova-Roche L.A. The role of pro-inflammatory S100A9 in Alzheimer's disease amyloid-neuroinflammatory cascade. Acta Neuropathol. 2014, 127:507-522.
278. Wang H.C., Bloom O., Zhang M.H., Vishnubhakat J.M., Ombrellino M., Che J.T., Frazier A., Yang H., Ivanova S., Borovikova L., Manogue K.R., Faist E., Abraham E., Andersson J., Andersson U., Molina P.E., Abumrad N.N., Sama A., Tracey K.J. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248-251.
279. Weng N. Aging of the immune system: how much can the adaptive immune system adapt?. Immunity 2006, 24:495-499.
280. World Health Organization (WHO) Draft WHO guidelines on the use of vaccines and antivirals during influenza pandemics. Wkly. Epidemiol. Rec. 2002, 77:394-404.
281. WHO, 2005. Influenza pandemic preparedness and response. Geneva, Executive Board rapport-EB115/44.
282. World Health Organization Human infection with new influenza A (H1N1) virus: Mexico, update, March-May 2009. Wkly. Epidemiol. Rec. 2009, 23:213-236.
283. World Health Organization, 2010. Situation Updates. (Cited July 10). Available from:. http://www.who.int/csr/disease/swineflu/updates/en/index.html.
284. WHO, 2014. Published its first global report on surveillance of antimicrobial resistance (Fact sheet N(194). http://www.who.int/mediacentre/factsheets/fs194/en/.
285. Wilkinson T.M., Li C.K., Chui C.S., Huang A.K., Perkins M., Liebner J.C., Lambkin-Williams R., Gilbert A., Oxford J., Nicholas B., Staples K.J., Dong T., Douek D.C., McMichael A.J., Xu X.N. Pre-existing influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat. Med. 2012, 18:274-280.
286. Wong C.P., Magnusson K.R., Ho E. Aging is associated with altered dendritic cells subset distribution and impaired proinflammatory cytokine production. Exp. Gerontol. 2010, 45:163-169.
287. Xi Y., Shao F., Bai X.Y., Cai G., Lv Y., Chen X. Changes in the expression of the Toll-like receptor system in the aging rat kidneys. PLoS One 2014, 9:e96351.
288. Xu T., Qiao J., Zhao L., Wang G., He G., Li K., Tian Y., Gao M., Wang J., Wang H., Dong C. Acute respiratory distress syndrome induced by avian influenza A (H5N1) virus in mice. Am. J. Respir. Crit. Care Med. 2006, 174:1011-1017.
289. Xu X., Chen H., Zhu X., Ma Y., Liu Q., Xue Y., Chu H., Wu W., Wang J., Zou H. S100A9 promotes human lung fibroblast cells activation through receptor for advanced glycation end-product-mediated extracellular-regulated kinase 1/2, mitogen-activated protein-kinase and nuclear factor-(B-dependent pathways. Clin. Exp. Immunol. 2013, 173:523-535.
290. Xue Y., Kristiansen I.S., de Blasio B.F. Modeling the cost of influenza: the impact of missing costs of unreported complications and sick leave. BMC Public Health 2010, 10:724. 20; 10.
291. Yager E.J., Ahmed M., Lanzer K., Randall T.D., Woodland D.L., Blackman M.A. Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus. J. Exp. Med. 2008, 205:711-723.
292. Yamada Y., Limmon G.V., Zheng D., Li N., Li L., Yin L., Chow V.T., Chen J., Engelward B.P. Major shifts in the spatio-temporal distribution of lung antioxidant enzymes during influenza pneumonia. PLoS One 2012, 7(2):e31494.
293. Yamane K., Indalao I.L., Chida J., Yamamoto Y., Hanawa M., Kido H. Diisopropylamine dichloroacetate, a novel pyruvate dehydrogenase kinase 4 inhibitor, as a potential therapeutic agent for metabolic disorders and multiorgan failure in severe Influenza. PLoS One 2014, 9:e98032.
294. Yan W.X., Armishaw C., Goyette J., Yang Z., Cai H., Alewood P., Geczy C.L. Mast cell and monocyte recruitment by S100A12 and its hinge domain. J. Biol. Chem. 2008, 283:13035-13043.
295. Yang C., Maiguel D.A., Carrier F. Identification of nucleolin and nucleophosmin as genotoxic stress-responsive RNA-binding proteins. Nucleic Acids Res. 2002, 30:2251-2260.
296. Yang D., Chen Q., Su S.B., Zhang P., Kurosaka K., Caspi R.R., Michalek S.M., Rosenberg H.F., Zhang N., Oppenheim J.J. Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD 88 signal pathway in dendritic cells and enhances Th2 immune responses. JEM 2008, 1-12.
297. Yang D., Oppenheim J.J. Antimicrobial proteins act as alarmins in joint immune defense. Arthritis Rheum. 2004, 50:3401-3403.
298. Yang D., Postnikov Y.V., Li Y., Tewary P., de la Rosa G., Wei F., Klinman D., Gioannini T., Weiss J.P., Furusawa T., Bustin M., Oppenheim J.J. High-mobility group nucleosome-binding protein 1 acts as an alarmin and is critical for lipopolysaccharide-induced immune responses. J. Exp. Med. 2012, 209:157-171.
299. Yanga D., Chena Q., Schmidtc A.P., Andersonc G.M., Wanga J.M., Woodtersd, Oppenheima J.J., Chertovb O. Ll-37, the neutrophil granule-and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (Fprl1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T Cells. JEM 2000, 192:1069-1074.
300. Yewdell J., Garcia-Sastre A. Influenza virus still surprises. Curr. Opin. Microbiol. 2002, 5:414-418.
301. Yin L., Zheng D., Limmon G.V., Leung N.H.N., Xu S., Rajapakse J.C., Yu H., Chow V.T.K., Chen J. Aging exacerbates damage and delays repair of alveolar epithelia following influenza viral pneumonia. Respir. Res. 2014, 15:116.
302. Youm Y., Grant R.W., McCabe L.R., Albarado D.C., Nguyen K.Y., Ravussin A., Pistell P., Newman S., Carter R., Laque A., Münzberg H., Rosen C.J., Ingram D.K., Salbaum J.M., Dixit V.D. Canonical Nlrp3 inflammasome links systemic low grade inflammation to functional decline in aging. Cell Metab. 2013, 18:519-532.
303. Yu V.L., Chiou C.C., Feldman C., Ortqvist A., Rello J., Morris A.J., Baddour L.M., Luna C.M., Snydman D.R., Ip M., Ko W.C., Chedid M.B.F., Andremont A., Klugman K.P. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin. Infect. Dis. 2003, 37:230-237.
304. Zheng D., Limmon G.V., Yin L., Leung N.H., Yu H., Chow V.T., Chen J. A cellular pathway involved in clara cell to alveolar Type II cell differentiation after severe lung injury. PLoS One 2013, 8(8):e71028.
305. Zhou X., McElhaney J.E. Age-related changes in memory and effector T cells responding to influenza A/H3N2 and pandemic A/H1N1 strains in humans. Vaccine 2011, 29:2169-2177.
306. Zhou Z., Yamamoto Y., Sugai F., Yoshida K., Kishima Y., Sumi H., Nakamura H., Sakoda S. Hepatoma-derived growth factor is a neurotrophic factor harbored in the nucleus. J. Biol. Chem. 2004, 279:27320-27326.
307. Zibouche M., Vincent M., Illien F., Gallay J., Ayala-Sanmartin J. The N-terminal Domain of Annexin 2 Serves as a Secondary Binding Site during Membrane Bridging. J. Biol. Chem. 2008, 283:22121-22127.
308. Zitvogel L., Kepp O., Galluzzi L., Kroemer G. Inflammasomes in carcinogenesis and anticancer immune responses. Nat. Immunol. 2012, 13(4):343-351.
309. Zou Y., Jung K.J., Kim J.W., Yu B.P., Chung H.Y. Alteration of soluble adhesion molecules during aging and their modulation by calorie restriction. FASEB J. 2004, 18:320-322.